Your browser doesn't support javascript.
loading
Antiviral Activity of Type I, II, and III Interferons Counterbalances ACE2 Inducibility and Restricts SARS-CoV-2.
Busnadiego, Idoia; Fernbach, Sonja; Pohl, Marie O; Karakus, Umut; Huber, Michael; Trkola, Alexandra; Stertz, Silke; Hale, Benjamin G.
Afiliação
  • Busnadiego I; Institute of Medical Virology, University of Zurich, Zurich, Switzerland.
  • Fernbach S; Institute of Medical Virology, University of Zurich, Zurich, Switzerland.
  • Pohl MO; Life Science Zurich Graduate School, ETH and University of Zurich, Zurich, Switzerland.
  • Karakus U; Institute of Medical Virology, University of Zurich, Zurich, Switzerland.
  • Huber M; Institute of Medical Virology, University of Zurich, Zurich, Switzerland.
  • Trkola A; Institute of Medical Virology, University of Zurich, Zurich, Switzerland.
  • Stertz S; Institute of Medical Virology, University of Zurich, Zurich, Switzerland.
  • Hale BG; Institute of Medical Virology, University of Zurich, Zurich, Switzerland stertz.silke@virology.uzh.ch hale.ben@virology.uzh.ch.
mBio ; 11(5)2020 09 10.
Article em En | MEDLINE | ID: mdl-32913009

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Antivirais / Pneumonia Viral / Interferon Tipo I / Interferons / Interferon gama / Infecções por Coronavirus / Peptidil Dipeptidase A Tipo de estudo: Prognostic_studies Limite: Aged / Animals / Female / Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Antivirais / Pneumonia Viral / Interferon Tipo I / Interferons / Interferon gama / Infecções por Coronavirus / Peptidil Dipeptidase A Tipo de estudo: Prognostic_studies Limite: Aged / Animals / Female / Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article